TSN 2024

Scientific Program

  • 【ISN-TSN International Conference I】Translational Medicine for Future Nephrology
  • Chair:Mai-Szu Wu、Masaomi Nangaku、Chih-Wei Yang、Toshio Miyata
Time (UTC+8) Topic Speaker Abstract
15:00 - 15:10 Opening
Mai-Szu Wu
15:10 - 15:35 1.Current and future perspectives of telenephrology
Masaomi Nangaku
15:36 - 16:00 2.Innovative medical device and AI-based software for kidney disease
Toshio Miyata
16:00 - 16:25 3.What we learn from multi-omics analyses
Reiko Inagi
16:30 - 16:45 4.From bench to bedside: Immunometabolic regulation for kidney disease
Huang-Yu Yang
16:45 - 17:00 5.Expanding biotechnology business landscape: industry-academia collaboration
John Tsung-chun Lee
17:00 - 17:10 Panel Discussion
17:10 - 17:15 Closing
Mai-Szu Wu
  • 【ISN-TSN International Conference II】Advances in Kidney Research: Innovative Approaches and Novel Therapies
  • Chair:Mai-Szu Wu、Masaomi Nangaku
Time (UTC+8) Topic Speaker Abstract
10:35 - 11:00 1.New drugs for kidney disease; SGLT2 inhibitor, HIF-PH inhibitor, and beyond
Masaomi Nangaku
11:00 - 11:25 2.A kidney disease drug helps fight cancer and aging
Toshio Miyata
11:25 - 11:50 3.Organelle stress in kidney disease
Reiko Inagi
11:50 - 12:15 4.Pericyte-specific targeting for kidney disease and complication
Shuei-Liong Lin
12:15 - 12:25 Panel Discussion
12:25 - 12:30 Photo
  • 【Symposium 1】DM, inflammation, uremic toxin management for CVD
  • Chair:Horng-Rong Chang、I-Kuan Wang、Wen-Yi Li
Time (UTC+8) Topic Speaker Abstract
13:30 - 13:35 Opening
13:35 - 14:00 1.DM, inflammation, uremic toxin management for CVD
Tsung-Han Tsai
14:00 - 14:25 2.The Gordian knot-- Look into the CardioRenal Metabolic Syndrome
Wei-Ting Chang
14:25 - 14:50 3.Targeting endothelium in CKD and related CVD
Fan-Chi Chang
14:50 - 15:00 Panel Discussion
  • 【Symposium 2】Controversies in the Therapeutic Management of Volume in AKI Patients
  • Chair:Chih-Hsiang Chang、Yu-Feng Lin
Time (UTC+8) Topic Speaker Abstract
15:10 - 15:15 Opening
15:15 - 15:40 1.Implementing Green Initiatives in Critical Care: Necessary or Costly?
Kuo-Hua Lee
15:40 - 16:05 2.Fluid status and fluid responsiveness in AKI patients
Chia-Chun Lee
16:05 - 16:30 3.Interdisciplinary treatment strategies: Navigating the challenges and opportunities in volume management for cardiovascular and kidney diseases
Ting-Yu Chiou
16:30 - 16:40 Panel Discussion
  • 【腎臟病健康促進機構共學課程】提升腎臟病健康促進機構辦理腎臟病前端防治作業能力
  • Chair:蔡宜純
Time (UTC+8) Topic Speaker Abstract
09:00 - 09:20 早期腎臟病篩選、診斷及轉介
蔡宜純
09:20 - 09:40 提升腎臟前端防治能力_院所經驗分享
杜柏村
09:40 - 09:55 提升腎臟前端防治能力_院所經驗分享
蕭仕敏
  • 【Advanced CME for CKD nurse】Interdisciplinary care of chronic kidney disease and cardiovascular disease
  • Chair:Yi-Chun Tsai
Time (UTC+8) Topic Speaker Abstract
13:30 - 14:00 Experience of case management of heart failure
Yu-Chen Chung
14:00 - 14:30 Team intervention improves the care effectiveness for patients with myocardial infarction – the role of pharmacists
Shih-Han Wang
14:30 - 15:00 The effectiveness of exercise on frailty and sarcopenia in chronic kidney disease
Hsin-Yi Huang
  • 【Lunch Symposium 1】Sponsored by:Fresenius Medical Care Taiwan Co., Ltd.
  • Chair:Chun-Liang Lin
Time (UTC+8) Topic Speaker Abstract
12:30 - 13:20 How does the HVHDF changes dialysis patient QOL and the clinical application?
Peter J. Blankestijn
  • 【Symposium 3】Revisit Peritoneal Dialysis with Modern Mindset
  • Chair:Ming-Ju Wu、Chih-Yu Yang
Time (UTC+8) Topic Speaker Abstract
15:10 - 15:15 Opening
15:15 - 15:45 1. The role of PD in super-aged society
Mu-Chi Chung
15:45 - 16:15 2.Elderly patients on PD
Chieh-Li Yen
16:15 - 16:25 Panel Discussion
  • 【Symposium 4】Management of Cardiovascular Diseases in Kidney Transplant Recipients
  • Chair:Ping-Chin Lai、Cheng-Hsu Chen
Time (UTC+8) Topic Speaker Abstract
09:00 - 09:30 1.Medical and intervention therapy of arrhythmia in kidney transplant recipients
Yu-Cheng Hsieh
09:30 - 10:00 2.Medical and intervention therapy of heart failure in kidney transplant recipients
Hung-Tien Kuo
10:00 - 10:30 3.Diagnosis and interventional therapy of coronary heart disease in kidney transplant recipients
Tung-Min Yu
  • 【Lunch Symposium 2】Sponsored by:AstraZeneca Taiwan Limited
  • Chair:Ming-Ju Wu
Time (UTC+8) Topic Speaker Abstract
12:30 - 13:20 Management of complications in CKD: One more think while using reno-protective therapy
Shang-Feng Tsai
  • 【Symposium 5】HTN and hyperlipidemic control for CVD
  • Chair:Cheng-Hsu Chen、Sheng-Wen Wu、Ping-Fang Chiu
Time (UTC+8) Topic Speaker Abstract
13:30 - 13:35 Opening
13:35 - 14:00 1.News about blood pressure and lipid control in managing cardiovascular disease
C.Y. Wang
14:00 - 14:25 2.Optimizing blood pressure management in chronic kidney disease and diabetes: addressing controversies and evidence gaps
Edy Kornelius
14:25 - 14:50 3.The neurovascular consequences of cardio-renal syndrome: Exploring the pathways to cognitive impairment and stroke
Yen-Chung Chen
14:50 - 15:00 Panel Discussion
  • Case Communication 1
  • Chair:Wen-Chin Lee
Time (UTC+8) Topic Speaker Abstract
09:00 - 09:12 Transplant Renal Artery Stenosis
謝運芳
徐愷翔
09:12 - 09:24 Use of super high-flux hemodialysis,for treatment of HD Patients with Acquired perforating dermatosis
彭正清
09:24 - 09:36 Differential diagnosis consideration between diabetic nephropathy and preeclampsia: a case report
王昱珩
09:36 - 09:48 Disseminated Cryptococcosis Complicating ANCA Associated Vasculitis: A Case Report
陳維哲
09:48 - 10:00 Staphylococcus infection-associated glomerulonephritis in a renal transplant patient
王偉陵
徐佳鈿
10:00 - 10:12 A 23-year-old young woman with de novo thrombotic microangiopathy after ABO incompatible living donor kidney transplantation
尹玉聰
洪麗玉
廖家德
李明哲
吳美儀
10:12 - 10:24 Embolization of bilateral polycystic kidneys as an alternative to pre-transplantation nephrectomy in a patient with recurrent cyst hemorrhage
李明哲
吳美儀
劉小櫻
呂岳勳
高芷華
  • 【Lunch Symposium 3】Sponsored by:Novo Nordisk Taiwan
  • Chair:Ping-Chin Lai
Time (UTC+8) Topic Speaker Abstract
12:30 - 13:20 The Benefits of Semaglutide to People with Diabetes and Chronic Kidney Disease
Chih-Chao Yang
  • Case Communication 2
  • Chair:Paik-Seong Lim
Time (UTC+8) Topic Speaker Abstract
13:30 - 13:42 The Details Hidden within Diabetes: Interplay of Albumin-to-Globulin Ratio Reversal in Diabetes Mellitus and IgG4-Related Kidney Disease
柳向芃
丁瑞聰
巫宏傑
王偉傑
陳冬英
13:42 - 13:54 A 36-year-old female with lower urinary symptoms infection and bilateral vesicoureteral reflux
黃雅琳
陳清揚
13:54 - 14:06 Desensitization in a highly sensitized living donor kidney transplant
徐愷翔
陳宜宏
楊如燁
彭渝森
14:06 - 14:18 A case with hemophagocytic lymphohistiocytosis with perirenal tumor suspected aggressive lymphoma
黃翊安
洪毓權
14:18 - 14:30 Pleuroperitoneal communication: A silent killer in peritoneal dialysis patient
侯順方
14:30 - 14:42 A case of cyclosporine-resistant FSGS revealed renal amyloidosis in a second renal biopsy
徐愷翔
14:42 - 14:54 Immune-complex mediated glomerulonephritis secondary to lymphoma
林佩萱
陳泰迪
陳永昌
田亞中
方基存
楊智偉
塗昆樺
14:54 - 15:06 C3 glomerulonephritis with rapid progressive glomerulonephritis
陳泰迪
陳永昌
田亞中
方基存
楊智偉
塗昆樺
黃怡雯
  • 【Lunch Symposium 4】Sponsored by:Tai Tien PHARMACEUTICALS Co., Ltd.
  • Chair:Cheng-Hsu Chen
Time (UTC+8) Topic Speaker Abstract
12:30 - 13:20 Unlocking Therapeutic Potential of Renal Anemia in Dialysis Patients: Vadadustat, a Novel HIF-PH Inhibitor
Chia-Lin Wu
  • 【Lunch Symposium 5】Sponsored by:Eli Lilly and Company (Taiwan)
  • Chair:Mai-Szu Wu
Time (UTC+8) Topic Speaker Abstract
12:30 - 13:20 Practical guidance for the use of SGLT2 inhibitors in patients with Cardio-Renal-Metabolic disease
Mu-Chi Chung